Top Buy
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €121.75 | €130.00 | 6.776% |
| GSK plc | 1 | 0 | 0 | 0 | €20.18 | - | - |
| Novartis AG ADR | 1 | 0 | 0 | 0 | €90.80 | - | - |
| Ipsen S.A. | 1 | 0 | 0 | 0 | €115.40 | €109.00 | -5.546% |
| AstraZeneca plc | 1 | 0 | 0 | 0 | €141.30 | €165.00 | 16.773% |
| Koninklijke Philips Electronics | 2 | 0 | 1 | 0 | €24.79 | - | - |
| Smith & Nephew plc ADR | 2 | 0 | 0 | 0 | €22.80 | - | - |
| Veeva Systems A | 2 | 0 | 0 | 0 | €187.85 | - | - |
| Koninklijke Philips Electronics ADR | 2 | 1 | 0 | 0 | €25.00 | - | - |
| UCB S.A. | 2 | 0 | 0 | 0 | €121.70 | - | - |
| EssilorLuxottica SA | 3 | 0 | 0 | 0 | €201.50 | €204.50 | 1.489% |
| Fresenius Medical Care AG & Co KGaA ADR | 3 | 1 | 1 | 0 | €19.10 | €21.00 | 9.948% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Sanofi S.A. | 4 | 0 | 1 | 0 | €92.18 | €99.50 | 7.941% |
| Quest Diagnostics Inc. | 4 | 0 | 1 | 0 | €127.10 | €144.44 | 13.646% |
| Fresenius SE & Co. KGaA | 4 | 0 | 2 | 0 | €28.24 | - | - |
| GSK plc ADR | 4 | 0 | 0 | 0 | €40.60 | €35.00 | -13.793% |
| Fresenius Medical Care AG & Co KGaA ST | 6 | 0 | 0 | 0 | €40.30 | €48.50 | 20.347% |
| Becton, Dickinson & Co. | 8 | 0 | 0 | 0 | €224.20 | €262.02 | 16.871% |
| Universal Health Services B | 9 | 3 | 1 | 1 | €159.00 | €159.70 | 0.443% |
| Teleflex Inc. | 10 | 0 | 0 | 0 | €186.00 | €247.18 | 32.892% |
| Medtronic plc | 10 | 1 | 0 | 0 | €75.44 | €94.38 | 25.107% |
| Dentsply Sirona Inc. | 10 | 0 | 0 | 0 | €26.44 | €38.55 | 45.809% |
| Laboratory Corp. Of America (labcorp) | 11 | 0 | 2 | 0 | €186.00 | €237.94 | 27.925% |
| Henry Schein Inc. | 11 | 1 | 0 | 0 | €63.96 | €79.30 | 23.985% |